Thomas Ollila, MD

Thomas A. Ollila, MD


Thomas A. Ollila, MD, is a hematologist/oncologist at Lifespan Cancer Institute who focuses on lymphoma, including primary central nervous system lymphoma. He is also the medical director of cutaneous T-cell lymphoma clinic. He earned his medical degree from Drexel University College of Medicine and completed his residency in internal medicine and fellowship in hematology/oncology at Rhode Island Hospital.

Dr. Ollila's research interests include translational and clinical outcomes in lymphoma. In 2018, he was given the Conquer Cancer Foundation Merit Award by the American Society of Clinical Oncology. He is a member of the Alpha Omega Alpha Medical Honors Society, the American Society of Hematology and the American Society of Clinical Oncology. Outside of clinical practice, he is an associate program director of the hematology/oncology fellowship and director of fellowship research.



Lifespan Cancer Institute, Rhode Island Hospital
Ambulatory Patient Center (APC Building) (directions)
110 Lockwood St.
Providence, RI 02903


  • Medical School:  Drexel University College of Medicine, Philadelphia
  • Residency:  Rhode Island Hospital
  • Fellowship:  Rhode Island Hospital